BUSINESS● LOW4d ago · Oct 29, 2026, 10:13 AM
Eli Lilly is about to report earnings. Here's what to expect
CNBC · global
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS30m agoSBA Communications declares $1.25 dividendSeeking Alpha TechBUSINESS31m agoAustralia hikes rates to 18-year high to fight inflationCNBC